Mandraffino, G.; Morace, C.; Franzè, M.S.; Nassisi, V.; Sinicropi, D.; Cinquegrani, M.; Saitta, C.; Scoglio, R.; Marino, S.; Belvedere, A.;
et al. Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia. Biomedicines 2022, 10, 1770.
https://doi.org/10.3390/biomedicines10081770
AMA Style
Mandraffino G, Morace C, Franzè MS, Nassisi V, Sinicropi D, Cinquegrani M, Saitta C, Scoglio R, Marino S, Belvedere A,
et al. Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia. Biomedicines. 2022; 10(8):1770.
https://doi.org/10.3390/biomedicines10081770
Chicago/Turabian Style
Mandraffino, Giuseppe, Carmela Morace, Maria Stella Franzè, Veronica Nassisi, Davide Sinicropi, Maria Cinquegrani, Carlo Saitta, Riccardo Scoglio, Sebastiano Marino, Alessandra Belvedere,
and et al. 2022. "Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia" Biomedicines 10, no. 8: 1770.
https://doi.org/10.3390/biomedicines10081770
APA Style
Mandraffino, G., Morace, C., Franzè, M. S., Nassisi, V., Sinicropi, D., Cinquegrani, M., Saitta, C., Scoglio, R., Marino, S., Belvedere, A., Cairo, V., Lo Gullo, A., Scuruchi, M., Raimondo, G., & Squadrito, G.
(2022). Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia. Biomedicines, 10(8), 1770.
https://doi.org/10.3390/biomedicines10081770
